Sleep Disorders and Gastroesophageal Reflux Disease (GERD)

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

December 31, 2006

Conditions

InsomniaGERD

Interventions

DRUG

Rabeprazole

Trial Locations (1)

UNC Gastroenterology and UNC Sleep Disorders Center, Chapel Hill

All Listed Sponsors

collaborator

Janssen Pharmaceutica N.V., Belgium

INDUSTRY

lead

University of North Carolina

OTHER

NCT00287391 - Sleep Disorders and Gastroesophageal Reflux Disease (GERD) | Biotech Hunter | Biotech Hunter